Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of early granulocyte-colony-stimulating factor administration in the prevention of febrile neutropenia and impact on toxicity and efficacy of anti-CD19 CAR-T in patients with relapsed/refractory B-cell lymphoma.
Liévin R, Di Blasi R, Morin F, Galli E, Allain V, De Jorna R, Vercellino L, Parquet N, Mebarki M, Larghero J, de Kerviler E, Madelaine I, Caillat-Zucman S, Chevret S, Thieblemont C. Liévin R, et al. Among authors: mebarki m. Bone Marrow Transplant. 2022 Mar;57(3):431-439. doi: 10.1038/s41409-021-01526-0. Epub 2022 Jan 30. Bone Marrow Transplant. 2022. PMID: 35094012 Free PMC article.
Quality risk management of the chimeric antigen receptor T cell pharmaceutical circuit in one of the first qualified European centers.
Talarmin C, Kerob S, Cartier F, Madelaine I, Mukenyi S, Schwartz E, Boissel N, Baruchel A, Thieblemont C, Parquet N, Brignier A, Lesprit E, Desproges A, Magdelonnette L, Larghero J, Mebarki M. Talarmin C, et al. Among authors: mebarki m. Cytotherapy. 2020 Dec;22(12):792-801. doi: 10.1016/j.jcyt.2020.06.009. Epub 2020 Jul 27. Cytotherapy. 2020. PMID: 32732084
Positron emission tomography-imaging assessment for guiding strategy in patients with relapsed/refractory large B-cell lymphoma receiving CAR T cells.
Galtier J, Vercellino L, Chartier L, Olivier P, Tabouret-Viaud C, Mesguich C, Di Blasi R, Durand A, Raffy L, Gros FX, Madelaine I, Meignin V, Mebarki M, Rubio MT, Feugier P, Casasnovas O, Meignan M, Thieblemont C. Galtier J, et al. Among authors: mebarki m. Haematologica. 2023 Jan 1;108(1):171-180. doi: 10.3324/haematol.2021.280550. Haematologica. 2023. PMID: 35678029 Free PMC article.
Real-world characteristics of T-cell apheresis and clinical response to tisagenlecleucel in B-cell lymphoma.
Cuffel A, Allain V, Faivre L, Di Blasi R, Morin F, Vercellino L, Chevalier MF, Desnoyer A, de Jorna R, Madelaine I, Parquet N, Brignier AC, Thieblemont C, Larghero J, Caillat-Zucman S, Mebarki M. Cuffel A, et al. Among authors: mebarki m. Blood Adv. 2022 Aug 9;6(15):4657-4660. doi: 10.1182/bloodadvances.2022007057. Blood Adv. 2022. PMID: 35728051 Free PMC article. No abstract available.
Success of donor-derived CAR-T cells after failure of autologous CD19 CAR-T cells (tisagenlecleucel) in B-cell acute lymphoblastic leukaemia.
Dourthe ME, Yakouben K, David A, Thouvenin S, Chaillou D, Caillat-Zucman S, Cuffel A, Tardy C, Lainey E, Caye-Eude A, Arfeuille C, Delaugerre C, Chaix-Baudier ML, Naudin J, Auvin S, Bergaoui K, Merlat-Guitard AI, De Jorna R, Mebarki M, Dalle JH, Baruchel A. Dourthe ME, et al. Among authors: mebarki m. Br J Haematol. 2024 Jul;205(1):373-377. doi: 10.1111/bjh.19524. Epub 2024 May 12. Br J Haematol. 2024. PMID: 38735758 No abstract available.
42 results